4.3 Article

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes

Journal

DIABETIC MEDICINE
Volume 30, Issue 11, Pages 1342-1348

Publisher

WILEY
DOI: 10.1111/dme.12222

Keywords

-

Funding

  1. Peninsula National Institute for Health Research (NIHR) Clinical Research Facility
  2. Department of Health
  3. Peninsula Collaboration for Leadership in Applied Health Research and Care (PenCLAHRC)
  4. NIHR
  5. Wellcome Trust
  6. NIHR Exeter Clinical Research Facility
  7. Diabetes UK
  8. National Institute for Health Research [PDA/02/06/098, NIHR-HCS-P12-03-03, DRF-2010-03-72, NF-SI-0611-10219, ACF-2009-23-001] Funding Source: researchfish
  9. National Institutes of Health Research (NIHR) [NIHR-HCS-P12-03-03] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

AimsTo determine the prevalence and clinical characteristics of absolute insulin deficiency in long-standing Type 2 diabetes, using a strategy based on home urinary C-peptide creatinine ratio measurement. MethodsWe assessed the urinary C-peptide creatinine ratios, from urine samples taken at home 2h after the largest meal of the day, in 191 insulin-treated subjects with Type 2 diabetes (diagnosis age 45years, no insulin in the first year). If the initial urinary C-peptide creatinine ratio was 0.2nmol/mmol (representing absolute insulin deficiency), the assessment was repeated. A standardized mixed-meal tolerance test with 90-min stimulated serum C-peptide measurement was performed in nine subjects with a urinary C-peptide creatinine ratio 0.2nmol/mmol (and in nine controls with a urinary C-peptide creatinine ratio >0.2nmol/mmol) to confirm absolute insulin deficiency. ResultsA total of 2.7% of participants had absolute insulin deficiency confirmed by a mixed-meal tolerance test. They were identified initially using urinary C-peptide creatinine ratio: 11/191 subjects (5.8%) had two consistent urinary C-peptide creatinine ratios 0.2nmol/mmol; 9 of these 11 subjects completed a mixed-meal tolerance test and had a median stimulated serum C-peptide of 0.18nmol/l. Five of these 9 had stimulated serum C-peptide <0.2nmol/l and 9/9 subjects with urinary C-peptide creatinine ratio >0.2 had endogenous insulin secretion confirmed by the mixed-meal tolerance test. Compared with subjects with a urinary C-peptide creatinine ratio >0.2nmol/mmol, those with confirmed absolute insulin deficiency had a shorter time to insulin treatment (median 2.5 vs. 6years, P=0.005) and lower BMI (25.1 vs. 29.1kg/m(2), P=0.04). Two out of the five patients with absolute insulin deficiency were glutamic acid decarboxylase autoantibody-positive. ConclusionsAbsolute insulin deficiency may occur in long-standing Type 2 diabetes, and cannot be reliably predicted by clinical features or autoantibodies. Absolute insulin deficiency in Type 2 diabetes may increase the risk of hypoglycaemia and ketoacidosis, as in Type 1 diabetes. Its recognition should help guide treatment, education and management. The urinary C-peptide creatinine ratio is a practical non-invasive method to aid detection of absolute insulin deficiency, with a urinary C-peptide creatinine ratio > 0.2nmol/mmol being a reliable indicator of retained endogenous insulin secretion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available